MedTrace Logo

Effect of High Dose Intravenous Vitamin C in Severe Pneumonia

NCT05842382 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 484

Last updated 2024-06-20

No results posted yet for this study

Summary

This trial is a multicenter, randomized, double-blind, two-arm, parallel-group, placebo-controlled trial to investigate the effect of high dose intravenous (IV) Vitamin C as an adjunct to the standard of care for patients with severe pneumonia versus placebo in ICU.

Conditions

Interventions

DRUG

Active Ingredient

IV Vitamin C (12g/day)

DRUG

Placebo

IV dextrose 5%

Sponsors & Collaborators

  • Ain Medicare Sdn Bhd

    collaborator UNKNOWN

  • Clinical Research Centre, Malaysia

    lead OTHER

Principal Investigators

  • Calvin Wong Ke Wen, MBBS MRCP · Hospital Umum Sarawak, Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-12
Primary Completion
2025-12-31
Completion
2026-02-28

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05842382 on ClinicalTrials.gov